We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Wyeth Pharmaceuticals, a division of Wyeth, is adding 52 drug development positions
to open a second drug development line at its Wyeth BioPharma Campus in Andover.
XOMA intends, subject to market and other conditions, to sell approximately
$60 million principal amount of its Convertible Senior Notes due 2012 to qualified
institutional buyers pursuant to Section 4(2) and Rule 144A under the Securities
Act of 1933, as amended.
ESP Pharma, a niche pharmaceutical company focused on the acquisition, marketing
and late-stage development of life-saving acute-care therapeutics, has announced
the acquisition, by ESP Pharma, of U.S. and Canadian rights to Retavase (reteplase)
from Centocor, a biopharmaceutical operating company of Johnson & Johnson.
Tanabe Seiyaku has signed an addendum to its licensing agreement with Centocor
of Pennsylvania for Remicade, an anti-TNF-alpha monoclonal antibody preparation
developed by Centocor.
Rigel Pharmaceuticals and Pfizer have entered into a collaborative research
and license agreement for the development of inhaled products to treat allergic
asthma and other respiratory diseases.
India's parliament will shortly ratify new legislation protecting drug patents,
paving the way for the country to become a major pharmaceutical research center,
its trade minister said.
The September 2004 recall of pain reliever Vioxx took a heavy toll on Merck's
fourth quarter earnings, which plummeted by more than 20 percent as a result
of the action.
Merck's arthritis pain drug Vioxx might have caused as many as 140,000 cases
of serious coronary heart disease in the U.S. since its launch in 1999, according
to a study published by the British medical journal The Lancet.
FDA drug safety reviewers should have a new data-mining
tool this spring to help them evaluate the hundreds of thousands of reports
submitted annually to the Adverse Events Reporting System (AERS) -- a system
that is now more widely available to the public online.